Solar Eclipse on August 2: Why world will be under darkness for over 6 minutes in a rare 100-year phenomenon; is it visible in India?
total solar eclipse
, one of the longest of the 21st century. Spanning over Europe, North Africa, and the Middle East, the eclipse will bring 6 minutes and 23 seconds of total darkness in specific regions, allowing a rare and extended view of the Sun's corona. Unlike most solar eclipses that last under three minutes, this event is scientifically and visually remarkable. While it will not be fully visible in many parts of Asia and the Americas, its impact and visibility extend in varying degrees including parts of western India.
Solar Eclipse August 2: World to go dark for over 6 minutes; here's why
This rare celestial event occurs due to a perfect alignment: the Moon will be at its closest point to Earth (perigee), making it appear larger, while Earth will be near its farthest point from the Sun (aphelion), making the Sun appear slightly smaller. As a result, the Moon will fully cover the Sun for an extended duration. The eclipse's path near the equator also causes the Moon's shadow to move more slowly, further increasing the total time.
This eclipse is unique because of its extraordinary duration and geographical alignment. The path of totality — the narrow strip where the Moon completely blocks the Sun — will cross several high-population areas. According to Space.com, this will be the longest total solar eclipse viewable from land between 1991 and 2114, surpassing most others in both length and clarity of visibility.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around
Blinkist: Warren Buffett's Reading List
Undo
Totality will allow observers to see the solar corona, which is the Sun's outer atmosphere. This faint halo of plasma is typically hidden by the Sun's brightness and is visible only during a full eclipse — making this event highly valuable for solar scientists.
Solar Eclipse 2027: Countries that will witness
Southern Spain (including Cádiz)
North Africa (notably Tunisia, Algeria, Libya, and Egypt)
Saudi Arabia and Yemen
Oman and southern UAE
The city of Luxor, Egypt will be one of the best locations, offering the maximum duration of totality at 6 minutes and 23 seconds.
Will the 2027 Solar Eclipse be visible in India
Yes, parts of western and northwestern India will experience a partial solar eclipse on August 2, 2027. However, the eclipse will not reach totality in any Indian region. Regions likely to see partial eclipse:
Rajasthan
Gujarat
Maharashtra
Goa
The extent of obscuration will be modest in India, ranging from 10% to 30% of the Sun's surface, depending on location and local timing.
Solar Eclipse timing in India
The partial eclipse is expected to occur during late afternoon hours, likely between 4:00 PM and 6:00 PM IST, with variation depending on the city. Sunset may interfere with the viewing in some western coastal regions like Mumbai or Goa.
Note
: Since India is not in the path of totality, eclipse glasses will be required for all phases of the eclipse.
Solar Eclipse 2027: Scientific opportunities and research importance
This extended eclipse presents a rare opportunity for researchers to:
Observe solar corona dynamics over a longer period
Study solar flares, magnetic field behavior, and coronal mass ejections (CMEs)
Use spectroscopy to analyze chemical composition and temperature of the corona
Monitor environmental changes, such as shifts in temperature and animal behavior
Calibrate solar observation instruments for future missions (e.g., ESA's Solar Orbiter, NASA's Parker Solar Probe)
The length of totality will allow more detailed data collection than usual, making this eclipse critical for space weather studies and climate modeling.
Solar Eclipse 2027 viewing: Essential safety guidelines
For Total Eclipse regions:
Only remove eclipse glasses during totality when the Sun is fully obscured.
Immediately replace protection as soon as sunlight re-emerges.
For Partial Eclipse regions (including India):
Do not remove eye protection at any time.
ISRO-approved or ISO-certified eclipse glasses
Solar viewers
Avoid using ordinary sunglasses or unfiltered lenses.
Do not look at the eclipse through a phone camera, binoculars, or telescope without certified solar filters.
Equipment suggestions
Solar binoculars with solar filters
Pinhole projectors for indirect viewing
Eclipse apps for real-time tracking and augmented viewing experience
Live stream options provided by NASA and other global observatories
For Indian viewers, organizations like ISRO, Vigyan Prasar, and Planetary Society of India often conduct public outreach events and live broadcasts during eclipses.
Cultural and historical significance of Solar Eclipses in India
Solar eclipses have long held cultural and religious significance in India. In Hindu tradition, eclipses are associated with the myth of Rahu and Ketu, celestial demons who cause the Sun to be swallowed temporarily. Many temples close during the eclipse, and rituals such as fasting and cleansing baths in holy rivers are observed. While such beliefs persist, modern science has helped balance mythological interpretations with astronomical understanding, promoting safe and informed viewing practices.
Solar Eclipse 2027 related FAQs
Why is the August 2, 2027 solar eclipse lasting over 6 minutes?
This rare eclipse lasts longer due to two factors: the Moon will be at its closest point to Earth (perigee), making it appear larger, while Earth will be farthest from the Sun (aphelion), making the Sun appear smaller. This alignment allows the Moon to fully cover the Sun for 6 minutes and 23 seconds.
Which countries will experience total darkness during the eclipse?
The path of totality will pass through southern Spain, North African countries (Tunisia, Algeria, Libya, Egypt), and parts of the Middle East including Saudi Arabia, Yemen, and Oman. Luxor, Egypt, will see the longest totality.
Will the eclipse be visible in India?
Yes, but only as a partial solar eclipse in western and northwestern states such as Rajasthan, Gujarat, Maharashtra, and Goa. The Sun will be partially obscured (10%–30%), depending on location.
What time will the eclipse be visible in India?
The
partial eclipse in India
is expected between 4:00 PM and 6:00 PM IST, but timing will vary by city. Sunset may limit visibility in some western regions.
Is it safe to view the eclipse without protection?
No. In India and other partial eclipse zones, viewers must use ISRO-approved or ISO-certified solar glasses at all times. Ordinary sunglasses are not safe. Total eclipse viewers can only remove glasses briefly during full obscuration.
Also Read |
Solar Eclipse August 2 will bring 6 minutes of total darkness; Check, date, time, and visibility areas for a once-in-100-years phenomenon
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
ICMR study found Covid vaccination didn't raise risk of unexplained sudden deaths among young adults: J P Nadda
An ICMR study has found that Covid vaccination did not increase the risk of unexplained sudden deaths among young adults in India, Union Health Minister J P Nadda told Lok Sabha on Friday. Past Covid hospitalization, family history of sudden death and certain lifestyle behaviours increased the likelihood of unexplained sudden deaths. Explore courses from Top Institutes in Please select course: Select a Course Category MBA Healthcare Management MCA Others others Data Analytics Data Science Finance Design Thinking Leadership PGDM Data Science Cybersecurity Digital Marketing Technology Degree Public Policy Operations Management Artificial Intelligence CXO healthcare Project Management Product Management Skills you'll gain: Financial Management Team Leadership & Collaboration Financial Reporting & Analysis Advocacy Strategies for Leadership Duration: 18 Months UMass Global Master of Business Administration (MBA) Starts on May 13, 2024 Get Details Skills you'll gain: Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Duration: 24 Months Vellore Institute of Technology VIT Online MBA Starts on Aug 14, 2024 Get Details Responding to a question, Nadda said the Indian Council of Medical Research (ICMR) has informed that it and the National Centre for Disease Control (NCDC) explored two approaches to investigate the causes of sudden death. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy the Dip: Top 5 Dividend Stocks with Growth Potential Seeking Alpha Read More Undo The first approach was a retrospective case-control study to determine the risk factors associated with sudden death and the second approach of the study was to prospectively investigate sudden deaths in young adults using a virtual autopsy approach. The ICMR-National Institute of Epidemiology (NIE) conducted a study titled "Factors associated with unexplained sudden deaths among adults aged 18-45 years in India - A multicentric matched case-control study" at 47 tertiary care hospitals located across 19 states and Union territories during May-August 2023. Live Events Cases were apparently healthy individuals without any known co-morbidity, who suddenly (less than 24 hours of hospitalization or seen apparently healthy 24 hours before death) died of unexplained causes during October 1, 2021-March 31, 2023, Nadda stated. Four controls were included per case matched for age, gender and neighbourhood. Information was collected regarding data on COVID-19 vaccination/infection, post-Covid conditions, family history of sudden death, smoking, recreational drug use, alcohol frequency, binge drinking and vigorous-intensity physical activity two days before death among the cases or interviewed controls, he said. A total of 729 sudden death cases and 2916 controls were included in the analysis. It was observed that receiving two doses of Covid vaccine significantly reduced the odds of unexplained sudden death, Nadda stated. Past COVID-19 hospitalization, family history of sudden death, binge drinking 48 hours before death/interview, use of recreational drug/substance and performing vigorous-intensity physical activity 48 hours before death/interview increased the odds of sudden death. "Hence, the study observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India. Past COVID-19 hospitalization, family history of sudden death and certain lifestyle behaviours increased the likelihood of unexplained sudden death," he said. The second study, titled "Establishing the cause in sudden unexplained deaths in young" conducted by the All India Institute of Medical Sciences (AIIMS), Delhi with funding and in collaboration with ICMR, is a prospective work aimed at determining the common causes of sudden deaths in young adults. Early analysis of data from the study indicates that heart attacks, or myocardial infarction (MI), continue to be the leading cause of sudden death in this age group. Importantly, no major changes in the pattern of causes have been observed when compared with previous years before the Covid pandemic. Together, these two studies offer a more comprehensive understanding of sudden unexplained deaths in young adults in India, Nadda said. It has also been revealed that Covid vaccination does not appear to increase the risk, whereas, the role of underlying health issues, genetic predisposition and risky lifestyle choices does play a role in unexplained sudden deaths, he said.
The Hindu
an hour ago
- The Hindu
How robotics can help bridge the digital divide in tribal India
India's diversity extends beyond basic linguistics, bringing in cultural, socio-economic, and regional markers. This country is home to over one crore tribal residents whose history goes back thousands of years and makes up almost 9% of the total Indian population. However, despite having a large population, Indian tribal communities have remained underserved and marginalised for a long period. Global technological advancements could help bridge the digital divide to ensure inclusive growth. The term technological advancements is considerably broad if we look to apply it to bridging the digital divide in tribal India. At present, India and the rest of the world are placing tremendous emphasis on Artificial Intelligence (AI), Machine Learning (ML), Cloud, etc. This means that significant competition has already been involved in the space. However, one such discipline exists that is yet to receive simultaneous attention from the world — Robotics. Experiencing the digital divide Many tribal communities reside in regions that have historically not been developed due to several challenges. For instance, the remote areas of Jharkhand and Chhattisgarh have witnessed instability, and connectivity has borne the brunt of it. In the Seven Sister States or the northeastern part of the country, connectivity has once again been a challenge because of the terrain. However, modern digital technologies mean that these challenges can essentially be overcome, and the introduction of an interesting discipline such as Robotics that could be demonstrated first-hand can lead to significant developments. The digital divide of the Indian tribal communities is not only because of connectivity challenges but also because they live on the margins in terms of economic progress, social development and technology access. Yet, the emergence of new technologies has impacted them as well, and may help to advance their living standards. While Robotics could be a complex discipline at first glance, its real-world applications and demonstrations align perfectly for motivating the youth, and first-hand demonstrations help to overcome the misconception of complexity. Robotics can lend itself to the method of learning by doing. The devices are real things and working with them give a sense of satisfaction, rendering them attractive to young people, including tribal youth. Scope of development Though literacy rates among the ST population is relatively high, some 70%, the mother tongue would be the best mode of instruction for tribal communities, just like it is for any community. But conveying technology and technical terms in the native languages of Indian tribes has been a challenge. With the advancements in AI, however, it is possible to create small language models (SLMs) that are equipped with regional languages or dialects. Using these digital mediums for pedagogy enables the diverse tribal communities to not only learn about different technological disciplines, including Robotics in their mother tongue, but also practice the same. These SLMs are equipped with data banks, or digital libraries that can be further used to create a long-term knowledge-gathering process. By deploying this as part of the larger outreach process, the digital divide is not only bridged in an era-appropriate way but also boosts the the chances for tribal youth to join the community of highly trained tech professionals. As a result of this comprehensive effort, a long-term talent pipeline can be created between the tribal communities and the technology sector, developing the quality of life of the youth while also offering the industry stakeholders a steady supply of highly efficient professionals. The advent of new-age technology, such as AI-driven classrooms, learning solutions, and others, means that these tools can be made available to the most marginalised too. However, it must be a public-private affair, and such is the case that is taking place via different State governments introducing similar courses in the K12 curricula in schools, and the private sector bolstering it with community outreach campaigns. With the outreach process surrounding Robotics in the middle, long-term developments of the communities themselves can be made possible, and by tapping their untapped potential, India stands to gain massively going into the next decade. (Born in a remote town in Madurai, Tamil Nadu, Arun Prakash is Founder and CEO of GUVI, an HCL Group Company and an IIT-Madras & IIM-Ahmedabad incubated EdTech platform that offers free and paid coding and management courses in Hindi, Telugu, Kannada, Swahili, Bengali, Tamil, and so on.)
Mint
an hour ago
- Mint
India has the potential to be a global lab for scalable longevity solutions: Accel's Prashanth Prakash
Bengaluru-based wellness startup Biopeak had raised $3.5 million recently in a funding round led by Prashanth Prakash, founding partner of Accel Partners, that also saw participation from Manipal Group's Ranjan Pai through his investment vehicle Claypond Capital and Zerodha's Nikhil Kamath and Nithin Kamath. In this exclusive interview, Prakash talks about longevity as a concept and its importance in future. Excerpts: Hello Prashanth, what was the thought process behind this investment decision? The timing of this investment is deeply intentional. We are at a unique intersection in human health where diagnostics, artificial intelligence, and longevity science are converging with extraordinary speed. Biopeak is building an integrated, precision health system grounded in global science but tailored to the unique biological, environmental, and lifestyle factors of the Indian population. This is not just a business bet—it's a belief that India will lead the world in next-generation healthcare. The thought process was simple: medicine is shifting from reactive to predictive and preventive, and Biopeak is among the few platforms architecting that future in a scalable, scientifically grounded way. It will enable us to plot with unprecedented detail personalised health trajectories for a specific individual using multi-dimensional data collection, integration, and prediction. The focus on deeply personalised healthcare is going to be huge in the future. Right? The transition from universal averages to personalised insights will represent a revolution in how we detect, predict, prevent adverse events and build resilience reserves. This new model of Biology and AI-led medicine is an exciting paradigm for the future of healthcare in our country that investors are excited to back. What's your definition of longevity? Longevity, for us, is not merely about extending the lifespan but expanding the healthspan. Ensuring more years that are healthy, vital, and productive is more crucial. In the Indian context, this requires a unique balance: respect for traditional knowledge systems, alignment with evolving regulatory frameworks, and deep reliance on evidence-based science. We're combining cutting-edge diagnostics—from microbiome and metabolomics to imaging and functional genomics—with culturally compatible interventions and a powerful AI layer. Longevity for us in India means democratising access to health optimisation—life partnerships between human intelligence and machine precision, rooted in science, ethics, and scale. In ancient civilizations including India, people were said to have lived for a much longer span of time. How do you relate that to the work Biopeak is doing and the results it is hoping to achieve? While environmental and societal contexts have changed drastically, ancient systems often emphasised internal balance, rhythm with nature, and preventative health —all are core principles in today's longevity science. At Biopeak, we're not romanticising the past—we're modelling it. Using symbolic and generative AI frameworks, we're integrating timeless health principles with modern biological data to predict individual responses to pharmaceuticals, nutraceuticals, and lifestyle interventions. It's not about replicating ancient lifespans—it's about reclaiming biological potential by harmonising past wisdom with today's precision tools. Do you think longevity as a concept can be realistically spread to all sections of society? Or will it remain only an aspiration of the well-heeled? Longevity must not become a luxury. With AI at the core of Biopeak's platform, we can rapidly model and scale health solutions based on outcomes from higher-touch cases to broader population needs. What starts with the few can be democratised for the many through intelligent design, efficient diagnostics, and continuous learning from diverse cohorts. India has the potential to be a global lab for scalable longevity solutions—not by diluting science but by deploying it with cultural and economic sensitivity. Through our own longitudinal data leveraging interdisciplinary collaboration (Longevity India, an initiative of the Indian Institute of Science), we aim to identify markers of organ system malfunction before pathology sets in so that we can implement a health management program which will extend healthspan and improve the quality of life for the ageing population across all sections of society. At the core of Biopeak's offering, I believe, is a diagnostic system that includes tests like organic acid profiling, microbiome mapping, salivary cortisol rhythms, and whole-exome functional genomics. These are paired with imaging tools such as MRI, CT, and ECHO, as well as tissue-level screenings that examine markers like mineral levels, toxin load, and oxidative stress. Does this make Biopeak a unique company in the world? Yes, Biopeak is unique both in its scientific architecture and its population focus. It combines multiple high-resolution diagnostic modalities—molecular, functional, and structural—into a unified health intelligence platform. Each individual is paired with a biologist and clinician, and guided through a dynamic health roadmap. What further sets it apart is its South Asia-centric design, which considers the genetic, dietary, cultural, and environmental nuances of this region. Supported by research from institutions like IISc and informed by global best practices, Biopeak is not just another health company—it's a systems-level rethink of what human health can be in the 21st century. What's Medicine 4.0? What does it look to solve? What are its basic principles? Medicine 4.0 is the natural evolution of healthcare in the age of AI and high-resolution biology. It's defined by its longitudinal view of health, multisystem diagnostics, real-time feedback loops, and personalised intervention frameworks. It's not about treating symptoms—it's about continuously adapting to the evolving biology of the individual. This approach integrates international technologies, leverages big data with small, precise insights, and focuses on outcomes over time rather than episodic care. In short, it's predictive, participatory, personalised, and preventive. What do you think are the key pillars of the Medicine 4.0 framework as far as BioPeak is concerned? Biopeak leverages data from modern genomics, metabolomics, lipidomics, and metagenomics analytics to provide a molecular view of an individual's unique biology. This integration identifies systemic equilibrium for identifying subtle imbalances and hidden dysfunctions long before symptoms arise. From DXA scans for bone density to functional MRIs and real-time metabolic imaging, Biopeak employs cutting-edge tools that visualise internal systems and structural health markers. Using a hybrid AI approach, combining symbolic AI (for precise, rule-based interpretations) and generative AI (for pattern recognition and predictive modelling), Biopeak can detect complex biological interrelations and generate personalised health insights. What do you think are the limitations of the current health systems worldwide and in India? Globally and in India, health systems remain largely reactive, fragmented, and oriented around acute interventions rather than long-term prevention. There's a heavy focus on managing disease rather than predicting and reversing the conditions that lead to it. What's missing is a systems view—an integration of diagnostics, therapeutics, and lifestyle within a cohesive, continuously updating framework. People are treated as conditions, not as dynamic ecosystems. Long-term biological consequences of current choices are rarely factored into care. The foundation of Medicine 2.0 was built on population averages, with protocols and interventions developed based on data from extensive observational and interventional studies. While this approach helped standardise treatments, it does not account for individual variability. Each person's genetic framework, metabolism, lifestyle, and environment interactions are unique, making the n=1 (individual-first) model essential for true health optimisation. Biopeak is solving for precisely this: unifying the fragmented landscape into an intelligent, longitudinal system centred around the individual.
